Radboudumc spin-off Cell4Pharma is very pleased to announced it has successfully closed a major funding round, marking a significant milestone in their journey towards developing ciPTEC as the leading platform to study human renal biological interaction during the preclinical stages of drug development.
This successful fundraising effort is a testament to the hard work and commitment of their leadership-team, as well as the confidence that investors have in their vision for the future of medical research.
With this new injection of capital, Cell4Pharma is well-positioned to accelerate the development of innovative, animal-free drug discovery platforms and bring their medicine development programs to the next level.
Cell4Pharma believes that this achievement will help to catalyze the shift towards more ethical and sustainable practices in the pharmaceutical industry, and is excited to take the next steps towards a brighter future for both patients and animals alike.
Cell4pharma envisions a world where animal experiments are obsolete. To make this a reality they are starting with eliminating renal toxicity for compounds entering clinical stages of drug development. This ambition is driven by their human renal ciPTEC cell lines and its use within their growing global network of research professionals. Cell4Pharma believes that researchers deserve the best tools available in order to deliver their best work.
Related news items
Boosting the startup ecosystem in Nijmegen!22 June 2023
TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.read more
Meet Healthy Ideas, Healthy Returns2 June 2023
Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.read more
Help Cell4Pharma to reduce animal testing in drug development21 December 2022
More than 50 million animals are used for medical experiments each year in the United States alone. But we have an alternative!read more
Aftermovie Investment Day 2022 and a new date for 2023!13 December 2022
Over 100 scientists, investors, and entrepreneurs came together to accelerate innovation in healthcare by creating new business opportunities and forging strong public-private partnerships.read more
Successful matchmaking at Radboudumc Investment Day7 October 2022
On the 5th of October, over 100 scientists, investors and entrepreneurs came together at the second Radboudumc Investment Day, jointly hosted by Radboudumc, Oost NL and Briskr.read more